Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Koshi Ohishi"'
Autor:
Motohiko, Okano, Yuka, Sugimoto, Koshi, Ohishi, Kana, Miyazaki, Fumihiko, Monma, Naoyuki, Katayama
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(7)
Chronic myeloid leukemia (CML) typically causes leukocytosis rather than thrombocytosis. We encountered two women in their thirties with remarkable thrombocytosis, whose platelet counts were over 3,000×10
Autor:
Makoto Ikejiri, Naoyuki Katayama, Koshi Ohishi, Yoshitaka Hosaka, Hideo Wada, Katsuki Naitoh, Yoshiki Yamashita, Masakatsu Nishikawa, Takeshi Mastumoto
Publikováno v:
Thrombosis Research. 133:440-444
Background Thrombotic microangiopathy (TMA) is caused by various conditions, such as decreased a ADAMTS13 level, activated or injured vascular endothelial cells or activated platelets. This study examined the soluble platelet glycoprotein VI (sGPVI)
Publikováno v:
Seminars in Cell & Developmental Biology. 14:143-150
The Notch pathway is a widely utilized, evolutionarily conserved regulatory system that plays a central role in the fate decisions of multipotent precursor cells. Notch often acts by inhibiting differentiation along a particular pathway while permitt
Autor:
Nadim Mahmud, Yoshihiro Komada, Hiroshi Shiku, Hideya Ohashi, Nobuyuki Minami, Hidetsugu Mitani, Koshi Ohishi, Kazuhiro Nishii, Takayuki Sugawara, Masakatsu Nishikawa, Hiroto Araki, Masato Watanabe, Masahiro Masuya, Naoyuki Katayama
Publikováno v:
British Journal of Haematology. 105:470-477
Transforming growth factor-beta1 (TGF-beta1) acts directly on haemopoietic progenitor cells to regulate their growth. To investigate a possible link between the action of TGF-beta1 and cell death regulators such as bcl-2, we utilized Ba/F3 cells, the
Autor:
Felipe R. Lorenzo, Miho Sakakura, Eiji Usui, Hiroyuki Miyashita, Naoyuki Katayama, Natsuki Hoshino, Koshi Ohishi, Yuka Sugimoto, Kazuhiro Nishii, Hiroshi Shiku, Hiroto Araki
Publikováno v:
The hematology journal : the official journal of the European Haematology Association. 5(1)
We report a 31-year-old female with t(8;21)(q22;q22) acute myeloid leukemia (AML), M2 in the FAB classification. Complete remission was achieved with daunorubicin and cytarabine induction therapy followed by three courses of high-dose cytarabine cons
Autor:
Nobuyuki Minami, Koshi Ohishi, R. Itoh, Shigeru Shirakawa, Naoyuki Katayama, Minoru Sakurai, Ryuhei Tanaka, Yoshihiro Komada, Nadim Mahmud, Yumi Tanaka
Publikováno v:
Blood. 86(1)
Recent advances in molecular biology have led to the identification of hematopoietic growth factors that support and influence the proliferation of hematopoietic progenitor cells in vitro and in vivo. Although these factors have been extensively stud